Results 151 to 160 of about 7,531 (200)

Mapping Pediatric Seasonal Influenza Vaccine Safety and Immunogenicity Evidence: A Systematic Review of Clinical Trials. [PDF]

Vaccines (Basel)
Munoz A, Olivares B, Yepes-Perez Y, Chen Y, Ortiz J, Amin M, Zeng M.   +6 more
europepmc   +1 more source

Vacunación antigripal convencional frente a la vacuna de subunidades adyuvada con MF59

Atención Primaria, 2009
Torrecilla Rojas, María Amparo, González, Miguel Pedregal, García Rodriguez, Fermín, Ruiz Fernández, Josefa   +3 more
openaire   +1 more source

Relative Efficacy, Effectiveness and Safety of Newer and/or Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory-Confirmed Influenza in Individuals Aged 18 years and Over: Update of a Systematic Review. [PDF]

Rev Med Virol
Askar M, Ali KA, Batke M, Brugger T, Falman A, Robertson AH, Pérez JJ, Johansen K, de Jonge J, Krause TG, Külper-Schiek W, Meerpohl JJ, Melidou A, Nohynek H, Olmedo C, Olsson K, Pavlopoulou I, Piechotta V, Rubin J, Schlaberg J, Schmucker C, Siemens W, Stratil J, Učakar V, Wichmann O, Harder T.   +25 more
europepmc   +1 more source

The recent advances in vaccine adjuvants. [PDF]

Front Immunol
Xing J, Zhao X, Li X, Fang R, Sun M, Zhang Y, Song N.   +6 more
europepmc   +1 more source

Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy. [PDF]

Transpl Infect Dis
Hayek H, Hasan L, Amarin JZ, Qwaider YZ, Hamdan O, Rezende W, Dee KC, Chappell JD, Halasa NB.   +8 more
europepmc   +1 more source

Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms. [PDF]

NPJ Vaccines
Pineda-Peña AC, Hasegawa K, Pavot V, Berry C, Combadière B, Cortes-Garcia G, McDermott AB, Sridhar S.   +7 more
europepmc   +1 more source

IgG and Fc Receptor Genetic Variation Associates With Functional Antibody Responses in a DNA and Protein Candidate HIV Vaccine Trial. [PDF]

J Acquir Immune Defic Syndr
Conley HE, Oh SY, Garrett N, Kublin J, Monaco CL, Watts S, Jha S, Ferrari G, Tomaras GD, Geraghty DE, Chan C, Pollara J.   +11 more
europepmc   +1 more source

Immunogenicity and safety of the MF59-adjuvanted seasonal influenza vaccine in non-elderly adults: A systematic review and meta-analysis. [PDF]

PLoS One
Domnich A, Trombetta CS, Fallani E, Salvatore M.   +3 more
europepmc   +1 more source

Advances in the structure-based design of protein vaccines for respiratory infectious diseases. [PDF]

Comput Struct Biotechnol J
Tie X, Li J, Wu H, Weng R, Zhang Y, Li J, Chen K.   +6 more
europepmc   +1 more source

A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials. [PDF]

Emerg Microbes Infect
Moodie Z, Li SS, Giorgi EE, Williams LD, Dintwe O, Carpp LN, Chen S, Seaton KE, Sawant SS, Zhang L, Heptinstall J, Liu S, Grunenberg N, Tomaka F, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Ake JA, Vasan S, Pantaleo G, Frank I, Baden LR, Goepfert PA, Keefer M, Chirenje M, Hosseinipour MC, Mngadi K, Laher F, Garrett N, Bekker LG, De Rosa S, Andersen-Nissen E, Kublin JG, Lu S, Gilbert PB, Gray GE, Corey L, McElrath MJ, Tomaras GD.   +38 more
europepmc   +1 more source